Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SUMO1 anticorps (full length)

SUMO1 Reactivité: Humain WB, ELISA, IF, IHC (p) Hôte: Rat Monoclonal 4D12 unconjugated
N° du produit ABIN2452138
  • Antigène Voir toutes SUMO1 Anticorps
    SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
    Épitope
    • 16
    • 15
    • 15
    • 9
    • 8
    • 8
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    full length
    Reactivité
    • 96
    • 78
    • 73
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 100
    • 31
    • 2
    • 1
    • 1
    Rat
    Clonalité
    • 95
    • 41
    Monoclonal
    Conjugué
    • 64
    • 11
    • 8
    • 7
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SUMO1 est non-conjugé
    Application
    • 110
    • 50
    • 44
    • 41
    • 31
    • 27
    • 26
    • 21
    • 15
    • 8
    • 8
    • 7
    • 6
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Specificité
    Specific to human, simian, mouse and rat SUMO1.
    Réactivité croisée (Details)
    Not tested for other species
    Purification
    The antibody was produced in serum-free medium and purified by proprietary chromatography procedures under mild conditions.
    Stérilité
    Sterile filtered
    Immunogène
    Recombinant GST-fused human SUMO1 (full length)
    Clone
    4D12
    Isotype
    IgG2a kappa
    Top Product
    Discover our top product SUMO1 Anticorps primaire
  • Indications d'application
    1. Western blotting: 1/1,000
    2. Immunofluorescence staining: 1/100 dilution
    3. Immunohistochemistry,Frozen section: 1/100 dilution
    4. ELISA (assay dependent)
    Other applications have not been tested.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS (x1), 50 % glycerol. Azide and carrier free.
    Agent conservateur
    Azide free
    Stock
    -20 °C
    Stockage commentaire
    Upon arrival centrifuge briefly and store at -20 C.
  • Ulrich: "The fast-growing business of SUMO chains." dans: Molecular cell, Vol. 32, Issue 3, pp. 301-5, (2008) (PubMed).

    Saitoh, Uchimura, Tachibana, Sugahara, Saitoh, Nakao: "In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies." dans: Experimental cell research, Vol. 312, Issue 8, pp. 1418-30, (2006) (PubMed).

    Uchimura, Ichimura, Uwada, Tachibana, Sugahara, Nakao, Saitoh: "Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation." dans: The Journal of biological chemistry, Vol. 281, Issue 32, pp. 23180-90, (2006) (PubMed).

    Cheng, Bawa, Lee, Gong, Yeh: "Role of desumoylation in the development of prostate cancer." dans: Neoplasia (New York, N.Y.), Vol. 8, Issue 8, pp. 667-76, (2006) (PubMed).

  • Antigène
    SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
    Autre désignation
    SUMO1 (SUMO1 Produits)
    Synonymes
    anticorps DAP1, anticorps GMP1, anticorps OFC10, anticorps PIC1, anticorps SENP2, anticorps SMT3, anticorps SMT3C, anticorps SMT3H3, anticorps UBL1, anticorps hm:zeh0670, anticorps wu:fb74c02, anticorps wu:fd12c02, anticorps zgc:65934, anticorps zgc:85634, anticorps SUMO1, anticorps dap1, anticorps gmp1, anticorps ofc10, anticorps pic1, anticorps senp2, anticorps smt3, anticorps smt3c, anticorps sumo-1, anticorps sumo1, anticorps ubl1, anticorps xsumo-1, anticorps xsumo1, anticorps ARABIDOPSIS THALIANA SMALL UBIQUITIN-LIKE MODIFIER 1, anticorps ATSUMO1, anticorps F10M23.180, anticorps F10M23_180, anticorps SMALL UBIQUITIN-LIKE MODIFIER 1, anticorps SUM1, anticorps SUMO 1, anticorps small ubiquitin-like modifier 1, anticorps pigSUMO1, anticorps SENTRIN, anticorps SMTP3, anticorps SUMO-1, anticorps Smt3C, anticorps Ubl1, anticorps small ubiquitin-like modifier 1, anticorps small ubiquitin-like modifier 1 S homeolog, anticorps small ubiquitin-related protein 1, anticorps SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae), anticorps SMT3 suppressor of mif two 3 homolog 1 (yeast), anticorps small ubiquitin-like modifier 1 L homeolog, anticorps Sumo1, anticorps SUMO1, anticorps sumo1, anticorps sumo1.S, anticorps sumo-1, anticorps sumo1.L
    Sujet
    SUMO (Small Ubiquitin-like Modifier) proteins are a family of small proteins that are covalently attached to and detached from other proteins in cells to modify their function. Unlike ubiquitination, which targets proteins for degradation, SUMO modification plays a critical role in a number of cellular functions including nucleocytoplasmic transport, gene expression, cell cycle and formation of subnuclear structures such as promyelocytic leukemia (PML) bodies. There are three confirmed SUMO isoforms in human, SUMO1, SUMO2 and SUMO3. SUMO2 /3 show a high degree of similarity to each other and are distinct from SUMO1. Individual SUMO family members are all targeted to different proteins with diverse biological functions. SUMO-1 is conjugated to RanGAP, PML, p53 and IkappaB-alpha to regulate nuclear trafficking, formation of subnuclear structures, regulation of transcriptional activity and protein stability. SUMO1 is encoded as a 101 aa protein and first Met and C-terminal 4 aa are removed from the preprotein.
    UniProt
    P63165
    Pathways
    M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Vous êtes ici:
Support technique